Rare Disease
Poster Session: Poster Session A
Flemming Axelsen, MSC
– Associate Director Market Access, Xcenda, DenmarkKatharina Buesch
– PTC Therapeuticsw, Steinhausen/Zug, Zug, SwitzerlandRongrong Zhang
– PTC Therapeutics, SwedenKasia Szczepanska
– PTC Therapeutics, AustriaGregory Fuest
– PTC Therapeutics, Miami, FL, United StatesAlexis Russell, DNP
– Therapeutic Area Lead, Gene Therapy, PTC Therapeutics, Bend, OR, United States